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ABSTRACT
The objective of the study was to evaluate the performance of nitrate reductase assay (NRA) as a rapid, reli-
able and inexpensive method for drug-susceptibility testing (DST) of Mycobacterium tuberculosis against first-
line antitubercular drugs, such as rifampicin (RIF), isoniazid (INH), streptomycin (STR), and ethambutol 
(EMB). In total, 286 isolates were subjected to test by proportion method (PM) and NRA. By comparing the 
results of NRA with those of the gold standard PM, sensitivities and specificities were 98.4%, 97%, 88.5%, 
and 94.2% and 100%, 100%, 94%, and 99% for RIF, INH, STR, and EMB respectively. The positive predic-
tive values were 100%, 100%, 95%, and 98% for RIF, INH, STR, and EMB respectively. The negative values 
were 99%, 98%, 87%, and 96% for RIF, INH, STR, and EMB respectively. The median time of obtaining 
results was shorter using NRA (10 days) compared to PM (28 days). An excellent agreement was observed 
between the two phenotypic tests with the κ values of 0.98, 0.97, 0.81, and 0.93 for RIF, INH, STR, and 
EMB respectively. The results demonstrated that NRA is suitable for the early determination of INH and 
RIF resistance and has the potential to be a useful tool for rapid drug-sensitivity test of M. tuberculosis in 
resource-constrained settings.
Key words: Antitubercular agents; Mycobacterium tuberculosis; Drug resistance, Mutiple; Nitrate reductase 
assay; Tuberculosis, Multi-drug-resistant; India
INTRODUCTION
Tuberculosis (TB) remains the greatest cause of ill-
ness and death worldwide, especially in Asia and 
Africa, which have accounted for 55% and 31% of 
the cases respectively in 2007 (1). 
The first five countries in terms of total numbers 
of TB cases in 2007 were India (2 million), China 
(1.3 million), Indonesia (0.53 million), Nigeria 
(0.46 million), and South Africa (0.46 million). Of 
the 9.27 million incidences of TB cases throughout 
the world in 2007, an estimated 1.37 million (15%) 
were HIV-positive; 79% of these HIV-positive cases 
were in the African region, and 11% were in the 
South-East Asia region. Developing countries ac-
count for 95% of active TB cases and deaths due to 
TB worldwide (2). Malnutrition and poor sanitary 
conditions contribute to the large-scale occurrence 
of the disease. The HIV pandemic has also played a 
role in enhancing the burden of the disease all over 
the world (3).
In developing countries, many national TB-control 
programmes have failed because of their low case-
detection rates, and once a case is detected, cure may 
also be difficult because of poor case management 
and inadequate control of drug prescription (4). 
Furthermore, the most worrisome trend in recent 
years, which challenged the global prospects for 
TB control, is an increase in drug-resistant TB, 
particularly multidrug-resistant TB (MDR-TB), 
defined as resistance to at least rifampicin (RIF) 
and isoniazid (INH). Extensively drug-resistant TB 
(XDR-TB) occurs in MDR strains which are resistant 
to any fluoroquinolone and at least one of three 
injectable second-line aminoglycoside drugs, i.e. 
amikacin, kanamycin, or capreomycin. In response 
to the emergence of XDR-TB, the World Health 
Organization (WHO) is now calling for universal 
access to culture and DST by 2015 for all new Gupta A et al.
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pulmonary TB patients (5). According to the WHO, 
500,000 new cases of MDR-TB occur globally every 
year, and MDR-TB has been reported in 2.9% 
and 15.3% of new and previously-treated cases 
respectively (6).
There is an urgent demand for early and proper 
detection of MDR and XDR-TB cases for the effec-
tive management and control of TB. Conventional 
method, i.e. proportion method (PM), is the gold 
standard for DST of Mycobacterium tuberculosis (MTB) 
but has some limitations, such as cumbersomeness 
and long-turnaround time (TAT). In recent years, 
a multitude of techniques for rapid DST has been 
designed and evaluated, such as colorimetric redox 
method (7), radiometric method BACTEC 460-TB 
(8), commercial MGIT, E-tests (9,10), and molecular 
methods—Genotype MTBDRplus and INNO-LiPA 
(11,12). Most of these have proved their reliability 
and accuracy but are limited to developed countries 
only because of high expenses while others, such as 
colorimetric redox methods or nitrate reductase as-
say, need more evaluation in the field.
NRA—also called Griess method (13)—was first des- 
cribed by Angeby et al. (14). NRA is based on the 
principle that MTB has the capability of reducing 
nitrate to nitrite. The presence of nitrite can be de-
tected by addition of Griess reagent which changes 
the colour of the culture medium (15). Several stud-
ies evaluated the performance of NRA but only a 
few were in India (16-21). The present study was, 
therefore, conducted to evaluate the performance 
of NRA compared to the gold standard PM for DST 
of MTB. Susceptibility tests were performed for all 
four first-line antitubercular drugs, i.e. RIF, INH, 
streptomycin (STR), and ethambutol (EMB).
MATERIALS AND METHODS
Settings 
M. tuberculosis strains were isolated from clinical 
sputum specimens collected from three different 
TB centres of Varanasi and from specimens submit-
ted to the Department of Microbiology, Institute of 
Medical Sciences, Banaras Hindu University, India, 
for 22 months during January 2008–October 2009.
Mycobacterial strains 
In total, 286 strains of MTB were evaluated in the 
study. The isolates and sputum specimens were 
obtained from cases reported for pulmonary TB. 
H37Rv (ATCC 27294), and M. intracellulare (ATCC 
13950) strains served as nitrate-positive and ni-
trate-negative controls respectively. A known MDR 
strain was also used as control. All the strains were 
first confirmed for their nitrate reductase activi- 
ty (22), which is part of the routine biochemical 
tests. The strains were confirmed to be MTB based 
on their growth rates, pigmentation, colony mor-
phology, and biochemical tests, such as heat-stable 
catalase, niacin accumulation, and susceptibility to 
p-nitrobenzoic acid (PNB) (22). All the strains were 
sub-cultured in Lowenstein-Jensen (LJ) medium for 
four weeks before NRA was performed.
Antitubercular drugs
INH, STR, RIF, and EMB were obtained in powder 
form from Sigma (St Louis, Missouri, USA). Each 
drug was prepared at a concentration of 10 mg/mL 
in sterile distilled water, except RIF, which was dis-
solved in dimethylformamide (DMF). Stock solu-
tions were filter-sterilized and stored at -20 0C for 
not more than one month. 
Media
Conventional LJ medium was prepared as des- 
cribed by Canetti et al. (23). The LJ medium for 
NRA was prepared with a slight modification: 1 
mg/mL KNO3 was added to the LJ medium, with or 
without antibiotics, dissolved by stirring and then 
aliquoted and inspissated once for 50 minutes at 
80 0C. For NRA, the bottles containing LJ with an-
tibiotics and KNO3 were used in duplicates while 
control tubes were used in triplicate.
Griess reagent 
Fifty percent (vol/vol) concentrated hydrochlo-
ric acid (HCl), 0.2% (wt/vol) sulphanilamide, and 
0.1% (wt/vol) n-1-naphthylethylenediamine dihy-
drochloride were prepared in small volumes and 
were mixed shortly before use in the ratio: 1 part: 2 
part: 2 part respectively.
DST by PM
The PM was carried out on the LJ medium accord-
ing to the laboratory’s standard procedures with the 
recommended critical concentrations of 40 µg/mL 
for RIF, 0.2 µg/mL for INH, 2 µg/mL for EMB, and 4 
µg/mL for STR (23, 24).
DST by NRA
NRA was performed according to the method de-
scribed by Angeby et al. (14). Bacterial suspensions 
were made from a sub-cultured LJ tube by dis-
pensing two 1-µL loopfuls of bacteria in 0.5 mL of 
phosphate-buffered saline (PBS) (pH 7.4) in 7.5-mL 
screw-cap bottles containing a few 3-mm diameter 
glass beads and vortexed to obtain a uniform solu-
tion. To obtain the turbidity of McFarland standard 
no. 1, approximately 2.5 mL of PBS was added. Part Gupta A et al. NRA: a rapid method for DST of MTB
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of the suspension was diluted at 1:10 in PBS. For 
each strain, 0.2 mL of the undiluted suspension 
was inoculated into tubes containing the LJ medi-
um with KNO3 and the antibiotics in duplicates to 
reduce the risk of contamination and to assess the 
reproducibility of the test while 0.2 mL of the 1:10 
dilution was inoculated into three drug-free tubes 
containing LJ with KNO3. The latter tubes served 
as growth controls. The tubes were incubated at 
37 °C. After seven days, 0.5 mL of Griess reagent 
was added to one drug-free control tube. If any col-
our change could be observed, the corresponding 
antibiotic-containing tubes were also tested, and 
susceptibility results were read. If no colour change 
was observed in the growth control tube, this tube 
was discarded, and the other two control tubes and 
the antibiotic-containing tubes were re-incubated. 
The procedure was then repeated at day 10, using 
the second growth control, and if needed, also at 
day 14, using the last growth control tube. 
The results were classified as negative if no colour 
change of the medium was observed and positive if 
pink to violet colour appeared in the medium. An 
isolate was considered to be resistant to a certain 
drug if there was a colour change in the antibiotic-
containing tube in question greater than that in 
the 1:10 diluted growth control on the same day. 
Analysis of data 
The MedCalc software (MedCalc, Belgium) was 
used for calculating the statistical parameters, such 
as sensitivity, specificity, and accuracy. The predic-
tive values were calculated using the prevalence of 
RIF, INH, STR, and EMB resistance in all the TB cas-
es in Varanasi, India. The agreement between the 
NRA and the standard PM was determined by the 
κ-statistic. The κ value, a measure of test reliability, 
was interpreted as follows: <0.2 poor; 0.21-0.4 fair; 
0.41-0.6 moderate; 0.61-0.8 good; and ≥0.81 excel-
lent (25).
RESULTS
DST for the first-line antitubercular drugs, i.e. RIF, 
INH, STR, and EMB, was performed with 286 clini-
cal MTB isolates. The results of 107, 138, and 41 iso-
lates were obtained after 7, 10, and 14 days respec-
tively and were compared with those produced by 
the gold standard PM. The results are shown in the 
Table. For RIF, 123 and 161 strains were detected to 
be resistant and susceptible respectively by means 
of both the methods while two false-negative re-
sults were produced with the NRA. For INH, both 
the methods detected 126 resistant strains and 156 
susceptible strains; four false-negative results were 
obtained with the NRA. For EMB, 115 and 162 
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strains were identified as true-positive and true-
negative respectively by both the methods while 7 
and 2 strains were misidentified as susceptible 
and resistant respectively by NRA. For STR, 139 iso-
lates were correctly detected as resistant and 121 
as sensitive by both the methods; 26 isolates gave 
discrepant results, 18 of which were false-negative 
i.e. resistant by PM while being susceptible by NRA, 
and 8 isolates were false-positive i.e. susceptible by 
PM but resistant by NRA. An excellent agreement 
was found between the two tests with the κ val-
ues of 0.98, 0.97, 0.81, and 0.93 for RIF, INH, STR, 
and EMB respectively. The sensitivity of the NRA 
compared to that of PM was observed to be 98.4%,   
97%, 88.5%, and 94.2% for RIF, INH, STR, and EMB 
respectively. Specificities were 100%, 100%, 94%, 
and 99% for RIF, INH, STR, and EMB respectively. 
The positive predictive values were 100%, 100%, 
95%, and 98% for RIF, INH, STR, and EMB respec-
tively. The negative values were 99%, 98%, 87%, 
and 96% for RIF, INH, STR, and EMB respectively. 
The accuracy of NRA was high with the PM for RIF 
(99.2%), INH (98.5%), and EMB (96.6%), except for 
STR (91%). An excellent agreement was observed 
in the results for RIF and INH. A good correlation 
was also found for EMB whereas some problems ex-
isted in detecting STR resistance and susceptibility 
(Table).
DISCUSSION
The most worrisome trend during recent years is 
an increase in multidrug-resistant (i.e. resistant to 
RIF and INH) TB strains. Rapid detection of MDR 
strains is very important to restrict their spread in 
the population. Current methods for DST of MTB 
are either costly or very slow. So, a cost-effective 
and rapid drug-susceptibility method is required to 
guide the treatment of TB. Results of meta-analysis 
of Martin et al. about NRA suggest that the NRA is 
highly sensitive and specific for determining RIF- 
and INH-resistant TB in both culture isolates and 
directly on clinical sputum specimens (26). Most 
studies had a sensitivity of 95% or greater, and near-
ly all were 100% specific with high degree of accu-
racy. The average TAT was 5-12 days with indirect 
NRA and 14-21 days with direct NRA. The biggest 
asset of NRA is that there is no need to change the 
laboratory infrastructure as it is performed in the 
classical LJ medium, routinely used in TB laborato-
ries, with the addition of KNO3. There is no need of 
any sophisticated equipment or expensive reagent, 
making it a widely-used method. Results are easy to 
observe by a colour change of the medium.
In the present study, an excellent agreement be-
tween the results of NRA and PM was observed 
with the κ values of 0.98, 0.97, 0.81, and 0.93 for 
RIF, INH, STR, and EMB respectively. RIF together 
with INH are the most important drugs for the 
treatment of TB. Sensitivities of NRA for RIF and 
INH were 98.4% and 97% respectively whereas spe-
cificity was 100% for both the drugs. However, an 
acceptable result of NRA was also found for EMB, 
with sensitivity and specificity of 94.2% and 99% 
respectively but some problems existed in detect-
ing STR resistance. Other studies have also reported 
high sensitivity and specificity values for INH and 
RIF (14,27).
The accuracy with the PM was high for all the drugs 
used in this study, except STR which does not come 
under the standard level, according to the criteria 
established by the WHO/IUATLD Supranational 
Laboratory Network, which has proposed the ac-
curacy levels of 99.0% and 97.0% for RIF and INH 
respectively and 92.0% for EMB and STR as reason-
able performance goals for reference laboratories. 
Although it has been already reported that STR is a 
difficult drug to test even by standard methods (28), 
the performance of NRA for STR was not acceptable 
because the expected level of agreement (92%) was 
not achieved. However, the κ value of the tests for 
STR showed that there is an excellent agreement 
(0.81) between the two phenotypic tests. 
The performance of NRA was evaluated in a mul-
ticentre study by Martin et al. to ascertain the sus-
ceptibility of MTB against first-line antitubercular 
drugs (29). The accuracy was greater than 97% for 
INH, EMB, and RIF while that for STR was inferior 
(85.3%). In another study, Martin et al. reported 
the evaluation of NRA for ofloxacin, a second-line 
drug, and found complete agreement with the agar 
PM (30). Therefore, NRA has the capability to be 
used also for the evaluation of second-line drugs. In 
addition, Lemus et al. evaluated indirect NRA with 
320 strains of MTB and found an overall agreement 
of 98.8% between the NRA and the PM (31).
Recently, Khan and Sarkar have developed a dor-
mant stage-specific anti-TB screening protocol in 
microplate format using Wayne’s hypoxic model 
and nitrate reductase activity in M. bovis BCG (Ba-
cillus Calmette-Guérin) culture (32). They conclud-
ed that the assay provides an easy, inexpensive, 
rapid, robust and high-content screening tool to 
search novel anti-TB molecules against both active 
and dormant bacilli with signal to noise ratio and Z 
factor, i.e. 8.5 and 0.81 respectively.
With the objective of reducing the TAT of DST by 
omitting the pre-isolation step, the NRA has been 
applied directly on clinical sputum specimens. A 
full agreement was observed for the detection of Gupta A et al. NRA: a rapid method for DST of MTB
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RIF resistance while some discordant results were 
obtained for other drugs (33). Visalakshi et al. ob-
served sensitivity and specificity of the direct NRA 
and indirect PM to be 94% and 98%, and 100% and 
98% for RIF and INH respectively with an excellent 
agreement between the two tests (21). Moreover, 
Shikama et al. stated 100% sensitivity and specifici-
ty of NRA for RIF (34). In another study of Shikama 
et al., reproducibility of NRA was 100% for INH and 
EMB and 97% for STR and RIF, with 98.3% agree-
ment between the results of NRA and PM for INH 
and RIF (35). 
Syre et al. used colorimetric nitrate reductase-based 
antibiotic-susceptibility (CONRAS) test for DST of 
MTB against INH and RIF in liquid cultures (36). 
The results were produced within five days, indi-
cating that the CONRAS test is an alternative in all 
settings, particularly for resource-poor countries.
Being advantageous, NRA has some limitations, 
such as some strains (<1%) of MTB lack nitrate re-
ductase (37) rendering the test invalid. However, in 
our setting, we could not find any such strain in 
routine biochemical tests, including nitrate reduct-
ase test. In addition, nitrate might be reduced to ni-
tric oxide beyond nitrite which cannot be detected 
by Griess reagent. Hence, zinc-dust was added to 
all negative tubes (22). Zinc reduces nitrate rapidly, 
and a true-negative test will directly turn red while 
there will be no change in colour in a tube where 
reduction has passed beyond nitrite. Another pos-
sible limitation of NRA is that it can give positive 
results with atypical mycobacteria M. kansasii, M. 
szulgai, M. flavescens, M. terrae complex, and some 
rapid growers (37) while M. bovis is nitrate-nega-
tive.
Conclusions
Our results indicate that NRA is suitable for the early 
determination of INH and RIF resistance. On the 
basis of the findings, we conclude that NRA has the 
potential to be a useful tool for rapid DST of MTB in 
resource-poor countries with limited laboratory fa- 
cilities because of its low-cost, rapidness, reproduci-
bility of results, simplicity and lack of requirement   
of expensive reagents and equipment.
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